Brief: Orchard Therapeutics To Present Data From Neurometabolic Portfolio
27/08/2019 12:30
Aug 27 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS ANNOUNCES PRESENTATION OF DATA FROM
NEUROMETABOLIC PORTFOLIO AT UPCOMING SOCIETY FOR THE STUDY OF
INBORN ERRORS OF METABOLISM (SSIEM) 2019 ANNUAL SYMPOSIUM
Source text for Eikon: ID:nGNX9bFNRp
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln